Your FREE subscription will give you access to articles, research reports, Biopharma CEO Confidence quarterly reports and much more!

Laboratory Services Insights From the Life Sciences Experts at Kineticos

The expert team at Kineticos Life Sciences delivers value to our clients by maintaining a thorough understanding of the most current issues related to clinical labs, bioanalytical labs, central labs, and analytical (API) labs. Below are case studies, white papers, and articles from our knowledgeable laboratory services specialists.

Click the Tabs Below for Laboratory Services Case Studies, White Papers & Articles, and Blog

Case Studies
  • Pricing Strategy

    Situation: A global central laboratory services company was considering implementing a price increase across their lab services and requested Kineticos


    Read this Case Study

  • Medical Affairs Global Readiness

    Situation: As a NASDAQ traded oncology biotechnology company was preparing to expand globally, they requested Kineticos conduct a gap assessment


    Read this Case Study

  • Business Development & Licensing Support

    Situation: An innovative oncology diagnostics company retained Kineticos to assist in developing their pitch deck, as well as developing and


    Read this Case Study

  • Brand Strategy

    Situation: A fully integrated Contract Development and Manufacturing Organization was merging with a company with overlapping capabilities and requested that


    Read this Case Study

  • Commercial Assessment

    Situation: A mid-sized biotech company evaluating their Phase II Metabolic asset requested that Kineticos provide a commercial and financial assessment


    Read this Case Study

  • Tradeoff Analysis and Valuation

    Situation: A preclinical precision medicine biotech company, looking to leverage their genome editing platform technology, was seeking support in narrowing


    Read this Case Study

  • Biotech Boards – 8 Things to Consider

    Written by Shailesh Maingi, CEO & Founder, Kineticos I’m often asked what it takes to have a great Board of


    Read this Article

  • A Primer on Oncology Diagnostics

    The trend towards personalized medicine in the oncology space has been rapidly gaining traction with the advent of genetic analysis


    Read this Article

  • Leveraging the Virtual Pharma Model

    Written by Mark Osterman, Senior Vice President, Kineticos My colleague, Dr. Soo Kim, recently wrote a piece about the evolution


    Read this Article

  • On the Importance of Primary Market Research

    Written by Myung Soo Kim, PhD, Research Analyst, Kineticos Pharmaceutical companies are frequently challenged with determining the optimal clinical development


    Read this Article

  • Continued Companion Diagnostics Growth

    Written by Bill Finger, Executive Vice President & Managing Director, Kineticos Since I last touched on how popular the companion


    Read this Article

  • A Primer on Demand Generation

    Written by Kevin Hampton, VP of Marketing, Kineticos Heading up Marketing for a start-up professional services company presents a variety


    Read this Article

  • How Metrics Can Help Identify and Solve Operational Challenges

    Article Preview As the sophistication of operational practices across life sciences increases; unfortunately, so do the difficulty and complexity of


    Read this Blog Post

  • Growth by Acquisition in Life Sciences: Do You Have a Plan?

    Article Preview As the life sciences landscape continually changes, growth by acquisition has become increasingly common. Recent deals, such as


    Read this Blog Post

  • R&D Revolutionaries: Why the Actavis/Allergan Deal Takes a Stand for Biopharma’s True Roots in Innovation

    James Forte of Kineticos takes an in-depth look at the recent Actavis/Allergan deal including the role R&D innovation played in shaping the deal’s outcome. Let’s be candid. It’s been awhile since any biopharma company was able to claim R&D as a core competency with a straight face. Biopharma’s R&D efforts have long been challenged, and rightly so given its output, but the Actavis/Allergan deal shows that the right investment in R&D can revolutionize a business. Could efficient R&D be the new definition of innovation?


    Read this Blog Post

  • Driving Revenue and EBIDTA at CROs through Customer Loyalty

    Article Preview Determining customer satisfaction and loyalty is a difficult endeavor for most businesses. Traditional voice of customer surveys are


    Read this Blog Post

  • Merck KGaA and Bayer Choose Opposite Strategies

    Article Preview Europe’s two largest chemical and drug conglomerates are changing course in starkly opposite ways. As reported in recent


    Read this Blog Post

  • Next Generation Sequencing: Using Technology to Develop Mutually-Beneficial Partnerships

    Article Preview Arup Laboratories announced it will begin offering next-generation sequencing (NGS) based high resolution Human Leukocyte Antigen (HLA) genotyping


    Read this Blog Post

Contact Us Today to Discover How We Can Elevate Your Business Our Strategy Consulting Services Are Designed to Enhance Your Value

Contact Us Today